Bradshaw C M, Sheridan R D, Szabadi E
Br J Pharmacol. 1985 Oct;86(2):483-90. doi: 10.1111/j.1476-5381.1985.tb08918.x.
The technique of microelectrophoresis was used to evaluate the relative contribution of D1 and D2 dopamine receptors towards the mediation of the excitatory response of single neurones to dopamine in the somatosensory cortex of the rat. The selective D1 dopamine receptor agonist, SKF 38393, failed to excite any of the cells to which it was applied. In contrast, the selective D2 dopamine receptor agonist, LY 171555, excited the majority of cells tested. The apparent potency of LY 171555 was significantly lower than that of dopamine. When the mobilities of SKF 38393 and LY 171555 were assessed by an in vitro method, they were found to be at least as great as those of dopamine and phenylephrine, suggesting that the lack of effect of SKF 38393 and the lower apparent potency of LY 171555 compared to dopamine reflect genuine biological phenomena. The alpha 1-adrenoceptor antagonist, prazosin, discriminated between excitatory responses to the alpha 1-adrenoceptor agonist, phenylephrine, and LY 171555: responses to phenylephrine were more susceptible to antagonism than were those to LY 171555. The dopamine receptor antagonist, haloperidol, produced the reverse discrimination: responses to LY 171555 were more affected than were those to phenylephrine. Neither antagonist reduced the response to the control agonist, acetylcholine. When applied continuously with low ejecting currents, LY 171555 antagonized the excitatory response to dopamine while the response to phenylephrine was relatively preserved. The response to acetylcholine was unaffected. When similarly applied, SKF 38393 had no selective action on the response to dopamine. 6 These results suggest that D2 dopamine receptors are involved in mediating the excitatory neuronal response to dopamine in the cerebral cortex, whereas DI dopamine receptors are unlikely to be involved. LY 171555 appears to act as a partial agonist at D2 dopamine receptors in this test system.
采用微电泳技术评估D1和D2多巴胺受体在介导大鼠体感皮层单个神经元对多巴胺的兴奋反应中所起的相对作用。选择性D1多巴胺受体激动剂SKF 38393未能兴奋其作用的任何细胞。相比之下,选择性D2多巴胺受体激动剂LY 171555兴奋了大多数受试细胞。LY 171555的表观效价比多巴胺低得多。当通过体外方法评估SKF 38393和LY 171555的迁移率时,发现它们至少与多巴胺和去氧肾上腺素的迁移率一样高,这表明SKF 38393缺乏作用以及LY 171555与多巴胺相比表观效价较低反映了真实的生物学现象。α1肾上腺素能受体拮抗剂哌唑嗪区分了对α1肾上腺素能受体激动剂去氧肾上腺素和LY 171555的兴奋反应:对去氧肾上腺素的反应比LY 171555的反应更容易受到拮抗作用的影响。多巴胺受体拮抗剂氟哌啶醇产生相反的区分:对LY 171555的反应比去氧肾上腺素的反应受影响更大。两种拮抗剂均未降低对对照激动剂乙酰胆碱的反应。当以低喷射电流持续应用时,LY 171555拮抗了对多巴胺的兴奋反应,而对去氧肾上腺素的反应相对保留。对乙酰胆碱的反应未受影响。同样应用时,SKF 38393对多巴胺的反应没有选择性作用。这些结果表明,D2多巴胺受体参与介导大脑皮层神经元对多巴胺的兴奋反应,而D1多巴胺受体不太可能参与其中。在该测试系统中,LY 171555似乎作为D2多巴胺受体的部分激动剂起作用。